Skip to content
2000
Volume 26, Issue 7
  • ISSN: 1389-4501
  • E-ISSN: 1873-5592

Abstract

Acne vulgaris is the 8th most commonly prevailing skin disorder worldwide. Its pervasiveness has been predominant in juveniles, especially males, during adolescence and in females during adulthood. The lifestyle and nutrition adopted have been significantly reported to impact the occurrence and frequency of acne. It typically occurs over the regions of the forehead, upper chest, and back of the body, which are regions with high proportions of active sebaceous follicles. The market today is flooded with the pool of anti-acne medications (oral, topical/systemic) that contain either a single therapeutic agent or a blend targeting multiple pathological pathways. However, the clinical applicability of these preparations is limited due to formulation stability, drug penetrability, and targeting, the incidence of secondary effects, antibiotic resistance, Moreover, the effectiveness of the former therapies varies as per the type and severity of acne. Therefore, it is necessary to extensively research skin physiology under normal and diseased conditions so that newer, safer, and more effective medications can be devised. Moreover, their safety and efficacy should be validated by employing various acne models, and their comparative profiling should be done with standard marketed anti-acne preparations. Acne models assist to uncover the complex disease pathogenesis and identify the potential targets for therapeutic interventions. This review is an attempt to highlight varied and testing procedures done to assess drug efficacy, track disease progression, and compare test substances with existing treatments. By presenting a unified approach to acne modeling, this review will assist researchers in selecting the most appropriate model for their specific research goals, helping them to generate valuable and reproducible data to support the development of effective acne therapies.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdt/10.2174/0113894501335548250123072644
2025-01-27
2025-09-01

  • From This Site

    /content/journals/cdt/10.2174/0113894501335548250123072644
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. VosT. FlaxmanA.D. NaghaviM. LozanoR. MichaudC. EzzatiM. ShibuyaK. SalomonJ.A. AbdallaS. AboyansV. AbrahamJ. AckermanI. AggarwalR. AhnS.Y. AliM.K. AlMazroaM.A. AlvaradoM. AndersonH.R. AndersonL.M. AndrewsK.G. AtkinsonC. BaddourL.M. BahalimA.N. Barker-ColloS. BarreroL.H. BartelsD.H. BasáñezM-G. BaxterA. BellM.L. BenjaminE.J. BennettD. BernabéE. BhallaK. BhandariB. BikbovB. AbdulhakA.B. BirbeckG. BlackJ.A. BlencoweH. BloreJ.D. BlythF. BolligerI. BonaventureA. BoufousS. BourneR. BoussinesqM. BraithwaiteT. BrayneC. BridgettL. BrookerS. BrooksP. BrughaT.S. Bryan-HancockC. BucelloC. BuchbinderR. BuckleG. BudkeC.M. BurchM. BurneyP. BursteinR. CalabriaB. CampbellB. CanterC.E. CarabinH. CarapetisJ. CarmonaL. CellaC. CharlsonF. ChenH. ChengA.T-A. ChouD. ChughS.S. CoffengL.E. ColanS.D. ColquhounS. ColsonK.E. CondonJ. ConnorM.D. CooperL.T. CorriereM. CortinovisM. de VaccaroK.C. CouserW. CowieB.C. CriquiM.H. CrossM. DabhadkarK.C. DahiyaM. DahodwalaN. Damsere-DerryJ. DanaeiG. DavisA. De LeoD. DegenhardtL. DellavalleR. DelossantosA. DenenbergJ. DerrettS. Des JarlaisD.C. DharmaratneS.D. DheraniM. Diaz-TorneC. DolkH. DorseyE.R. DriscollT. DuberH. EbelB. EdmondK. ElbazA. AliS.E. ErskineH. ErwinP.J. EspindolaP. EwoigbokhanS.E. FarzadfarF. FeiginV. FelsonD.T. FerrariA. FerriC.P. FèvreE.M. FinucaneM.M. FlaxmanS. FloodL. ForemanK. ForouzanfarM.H. FowkesF.G.R. FranklinR. FransenM. FreemanM.K. GabbeB.J. GabrielS.E. GakidouE. GanatraH.A. GarciaB. GaspariF. GillumR.F. GmelG. GosselinR. GraingerR. GroegerJ. GuilleminF. GunnellD. GuptaR. HaagsmaJ. HaganH. HalasaY.A. HallW. HaringD. HaroJ.M. HarrisonJ.E. HavmoellerR. HayR.J. HigashiH. HillC. HoenB. HoffmanH. HotezP.J. HoyD. HuangJ.J. IbeanusiS.E. JacobsenK.H. JamesS.L. JarvisD. JasrasariaR. JayaramanS. JohnsN. JonasJ.B. KarthikeyanG. KassebaumN. KawakamiN. KerenA. KhooJ-P. KingC.H. KnowltonL.M. KobusingyeO. KorantengA. KrishnamurthiR. LallooR. LaslettL.L. LathleanT. LeasherJ.L. LeeY.Y. LeighJ. LimS.S. LimbE. LinJ.K. LipnickM. LipshultzS.E. LiuW. LoaneM. OhnoS.L. LyonsR. MaJ. MabweijanoJ. MacIntyreM.F. MalekzadehR. MallingerL. ManivannanS. MarcenesW. MarchL. MargolisD.J. MarksG.B. MarksR. MatsumoriA. MatzopoulosR. MayosiB.M. McAnultyJ.H. McDermottM.M. McGillN. McGrathJ. Medina-MoraM.E. MeltzerM. MemishZ.A. MensahG.A. MerrimanT.R. MeyerA-C. MiglioliV. MillerM. MillerT.R. MitchellP.B. MocumbiA.O. MoffittT.E. MokdadA.A. MonastaL. MonticoM. Moradi-LakehM. MoranA. MorawskaL. MoriR. MurdochM.E. MwanikiM.K. NaidooK. NairM.N. NaldiL. NarayanK.M.V. NelsonP.K. NelsonR.G. NevittM.C. NewtonC.R. NolteS. NormanP. NormanR. O’DonnellM. O’HanlonS. OlivesC. OmerS.B. OrtbladK. OsborneR. OzgedizD. PageA. PahariB. PandianJ.D. RiveroA.P. PattenS.B. PearceN. PadillaR.P. Perez-RuizF. PericoN. PesudovsK. PhillipsD. PhillipsM.R. PierceK. PionS. PolanczykG.V. PolinderS. PopeC.A.III PopovaS. PorriniE. PourmalekF. PrinceM. PullanR.L. RamaiahK.D. RanganathanD. RazaviH. ReganM. RehmJ.T. ReinD.B. RemuzziG. RichardsonK. RivaraF.P. RobertsT. RobinsonC. De LeònF.R. RonfaniL. RoomR. RosenfeldL.C. RushtonL. SaccoR.L. SahaS. SampsonU. Sanchez-RieraL. SanmanE. SchwebelD.C. ScottJ.G. Segui-GomezM. ShahrazS. ShepardD.S. ShinH. ShivakotiR. SilberbergD. SinghD. SinghG.M. SinghJ.A. SingletonJ. SleetD.A. SliwaK. SmithE. SmithJ.L. StapelbergN.J.C. SteerA. SteinerT. StolkW.A. StovnerL.J. SudfeldC. SyedS. TamburliniG. TavakkoliM. TaylorH.R. TaylorJ.A. TaylorW.J. ThomasB. ThomsonW.M. ThurstonG.D. TleyjehI.M. TonelliM. TowbinJ.A. TruelsenT. TsilimbarisM.K. UbedaC. UndurragaE.A. van der WerfM.J. van OsJ. VavilalaM.S. VenketasubramanianN. WangM. WangW. WattK. WeatherallD.J. WeinstockM.A. WeintraubR. WeisskopfM.G. WeissmanM.M. WhiteR.A. WhitefordH. WiersmaS.T. WilkinsonJ.D. WilliamsH.C. WilliamsS.R.M. WittE. WolfeF. WoolfA.D. WulfS. YehP-H. ZaidiA.K.M. ZhengZ-J. ZoniesD. LopezA.D. MurrayC.J.L. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010.Lancet201238098592163219610.1016/S0140‑6736(12)61729‑223245607
     [Google Scholar]
  2. TasneemT. BegumA. ChowdhuryM.R.K. RahmanS. MacassaG. ManzoorJ. RashidM. Effects of acne severity and acne-related quality of life on depressive symptoms among adolescents and young adults: a cross-sectional study in Bangladesh.Front. Psychol.202314115310110.3389/fpsyg.2023.115310137554134
     [Google Scholar]
  3. CarminaE. DrenoB. LuckyW.A. AgakW.G. DokrasA. KimJ.J. LoboR.A. Ramezani TehraniF. DumesicD. Female adult acne and androgen excess: A report from the multidisciplinary Androgen Excess and PCOS committee.J. Endocr. Soc.202263bvac00310.1210/jendso/bvac00335155970
     [Google Scholar]
  4. LeungA.K.C. BarankinB. LamJ.M. LeongK.F. HonK.L. Dermatology: how to manage Acne vulgaris.Drugs Context20211011810.7573/dic.2021‑8‑634691199
     [Google Scholar]
  5. RathiS. Acne vulgaris treatment : The Current Scenario.Indian J. Dermatol.201156171310.4103/0019‑5154.7754321572783
     [Google Scholar]
  6. AminK. RiddleC.C. AiresD.J. SchweigerE.S. Common and alternate oral antibiotic therapies for Acne vulgaris: a review.J. Drugs Dermatol.20076987388017941358
     [Google Scholar]
  7. ThiboutotD. GollnickH. BettoliV. DrénoB. KangS. LeydenJ.J. ShalitaA.R. LozadaV.T. BersonD. FinlayA. GohC.L. HeraneM.I. KaminskyA. KubbaR. LaytonA. MiyachiY. PerezM. MartinJ.P. Ramos-e-SilvaM. SeeJ.A. ShearN. WolfJ.Jr Global Alliance to Improve Outcomes in Acne New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group.J. Am. Acad. Dermatol.2009605S1S5010.1016/j.jaad.2009.01.01919376456
     [Google Scholar]
  8. NewmanM.D. BoweW.P. HeughebaertC. ShalitaA.R. Therapeutic considerations for severe nodular acne.Am. J. Clin. Dermatol.201112171410.2165/11532280‑000000000‑0000021062102
     [Google Scholar]
  9. FeldmanS. CarecciaR.E. BarhamK.L. HancoxJ. Diagnosis and treatment of acne.Am. Fam. Physician20046992123213015152959
     [Google Scholar]
  10. OlutunmbiY. PaleyK. EnglishJ.C.III Adolescent female acne: etiology and management.J. Pediatr. Adolesc. Gynecol.200821417117610.1016/j.jpag.2007.07.00418656070
     [Google Scholar]
  11. BassiP. KaurG. Fenugreek gum derivatives with improved bioadhesion and controlled drug release: in vitro and in vivo characterization.J. Drug Deliv. Sci. Technol.201529425410.1016/j.jddst.2015.06.006
     [Google Scholar]
  12. HonK.L.E. LeungA.K. Acne: Causes, Treatment, and Myths.Nova Science Publishers2010
     [Google Scholar]
  13. LeungA.K. BarankinB. HonK. Adolescent Acne vulgaris: an overview of therapeutic options.Consultant Pediatr.2015146365
     [Google Scholar]
  14. ThiboutotD. DrénoB. SandersV. RuedaM.J. GollnickH. Changes in the management of acne: 2009-2019.J. Am. Acad. Dermatol.20208251268126910.1016/j.jaad.2019.04.01232303330
     [Google Scholar]
  15. ZouboulisC.C. BettoliV. Management of severe acne.Br. J. Dermatol.2015172S1273610.1111/bjd.1363925597508
     [Google Scholar]
  16. GrangeP.A. RaingeaudJ. CalvezV. DupinN. Nicotinamide inhibits Propionibacterium acnes-induced IL-8 production in keratinocytes through the NF-κB and MAPK pathways.J. Dermatol. Sci.200956210611210.1016/j.jdermsci.2009.08.00119726162
     [Google Scholar]
  17. GollnickH.P. ZouboulisC.C. Not all acne is Acne vulgaris.Dtsch. Arztebl. Int.20141111730131224828100
     [Google Scholar]
  18. ChenW. TsaiS.J. LiaoC.Y. TsaiR.Y. ChenY.J. PanB.J. HungC.L. ZouboulisC.C. Higher levels of steroidogenic acute regulatory protein and type I 3beta-hydroxysteroid dehydrogenase in the scalp of men with androgenetic alopecia.J. Invest. Dermatol.2006126102332233510.1038/sj.jid.570044216778788
     [Google Scholar]
  19. GeorgelP. CrozatK. LauthX. MakrantonakiE. SeltmannH. SovathS. HoebeK. DuX. RutschmannS. JiangZ. BigbyT. NizetV. ZouboulisC.C. BeutlerB. A toll-like receptor 2-responsive lipid effector pathway protects mammals against skin infections with gram-positive bacteria.Infect. Immun.20057384512452110.1128/IAI.73.8.4512‑4521.200516040962
     [Google Scholar]
  20. ThiboutotD.M. KnaggsH. GillilandK. HagariS. Activity of type 1 5 α-reductase is greater in the follicular infrainfundibulum compared with the epidermis.Br. J. Dermatol.199713621661719068725
     [Google Scholar]
  21. KimJ. OchoaM.T. KrutzikS.R. TakeuchiO. UematsuS. LegaspiA.J. BrightbillH.D. HollandD. CunliffeW.J. AkiraS. SielingP.A. GodowskiP.J. ModlinR.L. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses.J. Immunol.200216931535154110.4049/jimmunol.169.3.153512133981
     [Google Scholar]
  22. Ray JalianH. LiuP.T. KanchanapoomiM. PhanJ.N. LegaspiA.J. KimJ. All-trans retinoic acid shifts Propionibacterium acnes-induced matrix degradation expression profile toward matrix preservation in human monocytes.J. Invest. Dermatol.2008128122777278210.1038/jid.2008.15518563181
     [Google Scholar]
  23. NadkarniM.A. MartinF.E. JacquesN.A. HunterN. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set.Microbiology (Reading)2002148125726610.1099/00221287‑148‑1‑25711782518
     [Google Scholar]
  24. GuayD.R.P. Topical clindamycin in the management of Acne vulgaris.Expert Opin. Pharmacother.20078152625266410.1517/14656566.8.15.262517931096
     [Google Scholar]
  25. RevanK. MahendrakumarC.B. KiranB. Formulation and evaluation of hydroalcoholic extract of Berberis aristata DC. and Punica granatum Linn. for anti-acne action.Res J Pharm Technol20158111548155410.5958/0974‑360X.2015.00276.0
     [Google Scholar]
  26. GuH. AnH.J. GwonM.G. BaeS. ZouboulisC.C. ParkK.K. The effects of synthetic SREBP-1 and PPAR-γ decoy oligodeoxynucleotide on acne-like disease in vivo and in vitro via Lipogenic Regulation.Biomolecules20221212185810.3390/biom1212185836551286
     [Google Scholar]
  27. KahramanE. ÿzhanG. ÿzsoyY. GüngörS. Polymeric micellar nanocarriers of benzoyl peroxide as potential follicular targeting approach for acne treatment.Colloids Surf. B Biointerfaces201614669269910.1016/j.colsurfb.2016.07.02927434156
     [Google Scholar]
  28. KanwarI.L. HaiderT. KumariA. DubeyS. JainP. SoniV. Models for acne: A comprehensive study.Drug Discov. Ther.201812632934010.5582/ddt.2018.0107930674767
     [Google Scholar]
  29. RiddenJ. FergusonD. KealeyT. Organ maintenance of human sebaceous glands: in vitro effects of 13- cis retinoic acid and testosterone.J. Cell Sci.199095112513610.1242/jcs.95.1.1252351698
     [Google Scholar]
  30. PandeyM. ChoudhuryH. GunasegaranT.A.P. NathanS.S. MdS. GorainB. TripathyM. HussainZ. Hyaluronic acid-modified betamethasone encapsulated polymeric nanoparticles: fabrication, characterisation, in vitro release kinetics, and dermal targeting.Drug Deliv. Transl. Res.20199252053310.1007/s13346‑018‑0480‑129488170
     [Google Scholar]
  31. GollnickHP DessiniotiC ZouboulisCC New Drug Developments in Acne.AcneSpringer International Publishing202110.1007/978‑3‑030‑68996‑4_6
     [Google Scholar]
  32. Muguet GuenotL Vourc'h JourdainM Saint-JeanM CorvecS GaultierA KhammariA Confocal microscopy in adult women with acne.Int J Dermatol.201857327828310.1111/ijd.13910
     [Google Scholar]
  33. OmerH McDowellA AlexeyevOA Understanding the role of Propionibacterium acnes in Acne vulgaris: The critical importance of skin sampling methodologies.Clin. Dermatol.2017352118129
     [Google Scholar]
  34. KumariS PanditaD PooniaN LatherV Nanostructured lipid carriers for topical delivery of an anti-acne drug: characterization and ex vivo evaluation.Pharm. Nanotechnol.2015321223310.2174/221173850302151116124757
     [Google Scholar]
  35. MorganA LewisG Van den HovenW AkkerboomPJ The effect of zinc in the form of erythromycin-zinc complex (ZinerytR lotion) and zinc acetate on metallothionein expression and distribution in hamster skin.Br. J. Dermatol.1993129556357010.1111/j.1365‑2133.1993.tb00485.x8251353
     [Google Scholar]
  36. OliveiraC.M.M. AlmeidaL.M.C. BonamigoR.R. LimaC.W.G. BagatinE. Consensus on the therapeutic management of rosacea – Brazilian Society of Dermatology.An. Bras. Dermatol.202095Suppl 1536910.1016/j.abd.2020.08.00133172727
     [Google Scholar]
  37. VollmerD.L. WestV.A. LephartE.D. Enhancing skin health: By oral administration of natural compounds and minerals with implications to the dermal microbiome.Int. J. Mol. Sci.20181910305910.3390/ijms1910305930301271
     [Google Scholar]
  38. ZhangR. MeiyuL. ZhangJ. JinlianL. YanC. HuangZ. Research Progress on Establishing and Evaluation of Acne Animal Models.Laboratory Animal and Comparative Medicine.2023434398
     [Google Scholar]
  39. SansoneG. ReisnerR.M. Differential rates of conversion of testosterone to dihydrotestosterone in acne and in normal human skin-a possible pathogenic factor in acne.J. Invest. Dermatol.197156536637210.1111/1523‑1747.ep122612524253995
     [Google Scholar]
  40. RimonA. RakovC. LererV. Sheffer-LeviS. OrenS.A. ShlomovT. ShashaL. LubinR. ZubeidatK. JaberN. MujahedM. WilenskyA. Coppenhagen-GlazerS. Molho-PessachV. HazanR. Topical phage therapy in a mouse model of Cutibacterium acnes-induced acne-like lesions.Nat. Commun.2023141100510.1038/s41467‑023‑36694‑836813793
     [Google Scholar]
  41. KolarS.L. TsaiC.M. TorresJ. FanX. LiH. LiuG.Y. Propionibacterium acnes–induced immunopathology correlates with health and disease association.JCI Insight201945e12468710.1172/jci.insight.12468730843879
     [Google Scholar]
  42. SalemH.F. KharshoumR.M. AwadS.M. Ahmed MostafaM. Abou-TalebH.A. Tailoring of retinyl palmitate-based ethosomal hydrogel as a novel nanoplatform for Acne vulgaris management: fabrication, optimization, and clinical evaluation employing a split-face comparative study.Int. J. Nanomedicine2021164251427610.2147/IJN.S30159734211271
     [Google Scholar]
  43. PampaloniF. Reynaud e.g. StelzerE.H.K. The third dimension bridges the gap between cell culture and live tissue.Nat. Rev. Mol. Cell Biol.200781083984510.1038/nrm223617684528
     [Google Scholar]
  44. PokharkarVB MendirattaC KyadarkunteAY BhosaleSH BarhateGA Skin delivery aspects of benzoyl peroxide-loaded solid lipid nanoparticles for acne treatment.Ther. Deliv.20145663565210.4155/tde.14.3125090278
     [Google Scholar]
  45. HillP LoA EdenC HuntleyS MoreyV RamseyS Survey of the prevalence, diagnosis and treatment of dermatological conditions in small animals in general practice.Vet. Rec.20061581653353910.1136/vr.158.16.53316632525
     [Google Scholar]
  46. TalebM.H. AbdeltawabN.F. ShammaR.N. AbdelgayedS.S. MohamedS.S. FaragM.A. RamadanM.A. Origanum vulgare L. essential oil as a potential anti-acne topical nanoemulsion— in vitro and in vivo study.Molecules2018239216410.3390/molecules2309216430154336
     [Google Scholar]
  47. VoraJ SrivastavaA ModiH Antibacterial and antioxidant strategies for acne treatment through plant extracts.Inform. Med. Unl.20181312813210.1016/j.imu.2017.10.005
     [Google Scholar]
  48. OkamotoK. IkedaF. KanayamaS. NakajimaA. MatsumotoT. IshiiR. UmeharaM. GotohN. HayashiN. IyodaT. MatsuzakiK. MatsumotoS. KawashimaM. In vitro antimicrobial activity of benzoyl peroxide against Propionibacterium acnes assessed by a novel susceptibility testing method.J. Infect. Chemother.201622642642910.1016/j.jiac.2015.12.01026806150
     [Google Scholar]
  49. KimS.H. EomS.H. YuD. LeeM.S. KimY.M. Oligochitosan as a potential anti-Acne vulgaris agent: combined antibacterial effects against Propionibacterium acnes. Food Sci. Biotechnol.20172641029103610.1007/s10068‑017‑0118‑y30263633
     [Google Scholar]
  50. DuarteS. RosalenP.L. HayacibaraM.F. CuryJ.A. BowenW.H. MarquisR.E. RehderV.L.G. SartorattoA. IkegakiM. KooH. The influence of a novel propolis on mutans streptococci biofilms and caries development in rats.Arch. Oral Biol.2006511152210.1016/j.archoralbio.2005.06.00216054589
     [Google Scholar]
  51. BarerM.R. HarwoodC.R. Bacterial viability and culturability.Adv. Microb. Physiol.1999419313710.1016/S0065‑2911(08)60166‑610500845
     [Google Scholar]
  52. XiaL. ZouboulisC.C. JuQ. Culture of human sebocytes in vitro .Dermatoendocrinol200912929510.4161/derm.1.2.873620224690
     [Google Scholar]
  53. MirdamadiY. ThielitzA. WiedeA. GoihlA. ZouboulisC.C. BommhardtU. QuistS. GollnickH. Effects of isotretinoin on the phosphoinositide-3-kinase/Akt/FoxO1 pathway and molecular functions of SZ95 sebocytes in vitro .J. Clin. Exp. Dermatol. Res.20178310.4172/2155‑9554.1000399
     [Google Scholar]
  54. ZouboulisC.C. SeltmannH. OrfanosC.E. NeitzelH. Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95).J. Invest. Dermatol.199911361011102010.1046/j.1523‑1747.1999.00771.x10594745
     [Google Scholar]
  55. KovácsD. CameraE. PóliskaS. CavalloA. MaiellaroM. DullK. GruberF. ZouboulisC.C. SzegediA. TörőcsikD. Linoleic acid induced changes in SZ95 sebocytes—comparison with palmitic acid and arachidonic acid.Nutrients20231515331510.3390/nu1515331537571253
     [Google Scholar]
  56. ThiboutotD. GillilandK. CongZ. JabaraS. McAllisterJ.M. SivarajahA. ClawsonG. Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1).J. Invest. Dermatol.2003120690591410.1046/j.1523‑1747.2003.12244.x12787114
     [Google Scholar]
  57. LuJ. CongT. WenX. LiX. DuD. HeG. JiangX. Salicylic acid treats Acne vulgaris by suppressing AMPK / SREBP 1 pathway in sebocytes.Exp. Dermatol.201928778679410.1111/exd.1393430972839
     [Google Scholar]
  58. PappasA. FantasiaJ. ChenT. Age and ethnic variations in sebaceous lipids.Dermatoendocrinol20135231932410.4161/derm.2536624194973
     [Google Scholar]
  59. Lo CelsoC. BertaM.A. BraunK.M. FryeM. LyleS. ZouboulisC.C. WattF.M. Characterization of bipotential epidermal progenitors derived from human sebaceous gland: contrasting roles of c-Myc and β-catenin.Stem Cells20082651241125210.1634/stemcells.2007‑065118308950
     [Google Scholar]
  60. SinghP. BhatS.S. SinghN. VenkannaB.U. MohamedR. RaoR.P. Cell-based model systems for validation of various efficacy-based claims for cosmetic ingredients.Cosmetics20229510710.3390/cosmetics9050107
     [Google Scholar]
  61. LiH.Y. RenK. WangC. BuW.B. Skin organoid research progress and potential applications.Int. J. Dermatol. Venereol.20225210110610.1097/JD9.0000000000000201
     [Google Scholar]
  62. SommatisS. CapilloM.C. MaccarioC. LigaE. GrimaldiG. RausoR. BenciniP.L. GuidaS. ZerbinatiN. MocchiR. Biophysical and biological tools to better characterize the stability, safety and efficacy of a cosmeceutical for acne-prone skin.Molecules2022274125510.3390/molecules2704125535209043
     [Google Scholar]
  63. LabarrereC.A. WoodsJ.R. HardinJ.W. CampanaG.L. OrtizM.A. JaegerB.R. ReichartB. BonninJ.M. CurrinA. CosgroveS. PittsD.E. KirlinP.C. O’DonnellJ.A. HormuthD.A. WozniakT.C. Early prediction of cardiac allograft vasculopathy and heart transplant failure.Am. J. Transplant.201111352853510.1111/j.1600‑6143.2010.03401.x21219580
     [Google Scholar]
  64. ZouboulisC.C. XiaL. AkamatsuH. SeltmannH. FritschM. HornemannS. RühlR. ChenW. NauH. OrfanosC.E. The human sebocyte culture model provides new insights into development and management of seborrhoea and acne.Dermatology19981961213110.1159/0000178619557220
     [Google Scholar]
  65. SelwayJL KurczabT KealeyT LanglandsK Toll-like receptor 2 activation and comedogenesis: implications for the pathogenesis of acne.BMC Dermatol.2013131010.1186/1471‑5945‑13‑10
     [Google Scholar]
  66. HartmannV. HaritonW.V.J. RahimiS. HammersC.M. LudwigR.J. MüllerE.J. HundtJ.E. The human skin organ culture model as an optimal complementary tool for murine pemphigus models.Lab. Anim.202357438139510.1177/0023677222114564736647613
     [Google Scholar]
  67. ZouboulisCC Endocrinology and immunology of acne: Two sides of the same coin.Exp Dermatol.2020299840859
     [Google Scholar]
  68. OláhA. MarkovicsA. Szabó-PappJ. SzabóP.T. StottC. ZouboulisC.C. BíróT. Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrhoeic skin and acne treatment.Exp. Dermatol.201625970170710.1111/exd.1304227094344
     [Google Scholar]
  69. RazaK SinghB SingalP WadhwaS KatareOPJC Systematically optimized biocompatible isotretinoin-loaded solid lipid nanoparticles (SLNs) for topical treatment of acne.Colloids Surf. B Biointerfaces2013105677410.1016/j.colsurfb.2012.12.04323357735
     [Google Scholar]
  70. LeeC.J. ChenL.G. LiangW.L. WangC.C. Multiple activities of Punica granatum Linne against Acne vulgaris.Int. J. Mol. Sci.201718114110.3390/ijms1801014128085116
     [Google Scholar]
  71. OláhA. TóthB.I. BorbíróI. SugawaraK. SzöllõsiA.G. CzifraG. PálB. AmbrusL. KloepperJ. CameraE. LudoviciM. PicardoM. VoetsT. ZouboulisC.C. PausR. BíróT. Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes.J. Clin. Invest.201412493713372410.1172/JCI6462825061872
     [Google Scholar]
  72. CunninghamD. YouZ. In vitro and in vivo model systems used in prostate cancer research.J. Biol. Methods201521110.14440/jbm.2015.6326146646
     [Google Scholar]
  73. JainS. KaleD.P. SwamiR. KatiyarS.S. Codelivery of benzoyl peroxide & adapalene using modified liposomal gel for improved acne therapy.Nanomedicine (Lond.)201813121481149310.2217/nnm‑2018‑000229972675
     [Google Scholar]
  74. PatelR. PrabhuP. Nanocarriers as versatile delivery systems for effective management of acne.Int. J. Pharm.202057911914010.1016/j.ijpharm.2020.11914032061843
     [Google Scholar]
  75. ManfrediniM BettoliV SacripantiG FarnetaniF BigiL PuvianiM The evolution of healthy skin to acne lesions: A longitudinal, in vivo evaluation with reflectance confocal microscopy and optical coherence tomography.J. Eur. Acad. Dermatol. Venereol.20193391768177410.1111/jdv.1564131025401
     [Google Scholar]
  76. IlieM.A. CaruntuC. LixandruD. TampaM. GeorgescuS-R. ConstantinM-M. ConstantinC. NeaguM. ZuracS.A. BodaD. in vivo confocal laser scanning microscopy imaging of skin inflammation: Clinical applications and research directions.Exp. Ther. Med.20191721004101130679966
     [Google Scholar]
  77. AgamiaNF El MullaKF AlsayedNM GhazalaRM El MaksoudREA AbdelmeniemIM Isotretinoin treatment upregulates the expression of p53 in the skin and sebaceous glands of patients with Acne vulgaris.Arch. Dermatol. Res.202331551355136536585988
     [Google Scholar]
  78. HwangJ. JeongH. LeeN. HurS. LeeN. HanJ.J. JangH.W. ChoiW.K. NamK.T. LimK.M. Ex vivo live full-thickness porcine skin model as a versatile in vitro testing method for skin barrier research.Int. J. Mol. Sci.202122265710.3390/ijms2202065733440780
     [Google Scholar]
  79. LiuX. BarresiR. KaminerM. QianK. ThillouF. BataillonM. LiaoI.C. ZhengQ. BouezC. Utilization of ex vivo tissue model to study skin regeneration following microneedle stimuli.Sci. Rep.20221211811510.1038/s41598‑022‑22481‑w36302808
     [Google Scholar]
  80. PlewigG. MelnikB. ChenW. Plewig and kligman ́s acne and rosacea.Springer201910.1007/978‑3‑319‑49274‑2
     [Google Scholar]
  81. LuderschmidtC. EiermannW. JawnyJ. Steroid hormone receptors and their relevance for sebum production in the sebaceous gland ear model of the Syrian hamster.Arch. Dermatol. Res.1983275317518010.1007/BF005100496614993
     [Google Scholar]
  82. GunterN.V. TehS.S. LimY.M. MahS.H. Natural xanthones and skin inflammatory diseases: multitargeting mechanisms of action and potential application.Front. Pharmacol.20201159420210.3389/fphar.2020.59420233424605
     [Google Scholar]
  83. MiaoJ. ChardL.S. WangZ. WangY. Syrian hamster as an animal model for the study on infectious diseases.Front. Immunol.201910232910.3389/fimmu.2019.0232931632404
     [Google Scholar]
  84. BurkeB CunliffeWJ Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia.Br J Dermatol.1985112112412510.1111/j.1365‑2133.1985.tb02305.x
     [Google Scholar]
  85. RamliR MalikAS HaniAFM JamilA Acne analysis, grading and computational assessment methods: An overview.Skin Res. Technol.201218111410.1111/j.1600‑0846.2011.00542.x21605170
     [Google Scholar]
  86. WangJ LiaoY XiaJ WangZ MoX FengJ Mechanical micronization of lipoaspirates for the treatment of hypertrophic scars.Stem Cell Res. Ther.20191014210.1186/s13287‑019‑1140‑130678729
     [Google Scholar]
  87. XiaoS. YuH. XieY. GuoY. FanJ. YaoW. The acne-treatment potential of Cinnamomum Camphora Chvar. Borneol essential oil in vitro and in vivo .2021(PREPRINT).
     [Google Scholar]
  88. YamasakiK. GalloR.L. Antimicrobial peptides in human skin disease.Eur. J. Dermatol.2008181112118086583
     [Google Scholar]
  89. MalikD.S. KaurG. Exploring therapeutic potential of azelaic acid loaded NLCs for the treatment of Acne vulgaris.J. Drug Deliv. Sci. Technol.20205510141810.1016/j.jddst.2019.101418
     [Google Scholar]
  90. ValacchiG. De LucaC. WertzP.W. Lipid mediators in skin inflammation: updates and current views.Hindawi2010
     [Google Scholar]
  91. PaithankarD.Y. SakamotoF.H. FarinelliW.A. KositratnaG. BlomgrenR.D. MeyerT.J. FaupelL.J. KauvarA.N.B. LloydJ.R. CheungW.L. OwczarekW.D. SuwalskaA.M. KochanskaK.B. NawrockaA.K. PaluchowskaE.B. PodolecK.M. PirowskaM.M. Wojas-PelcA.B. AndersonR.R. Acne treatment based on selective photothermolysis of sebaceous follicles with topically delivered light-absorbing gold microparticles.J. Invest. Dermatol.201513571727173410.1038/jid.2015.8925748556
     [Google Scholar]
  92. DaviesM.A. Salicylic acid deposition from wash-off products: comparison of in vivo and porcine deposition models.Int. J. Cosmet. Sci.201537552653110.1111/ics.1222925899428
     [Google Scholar]
  93. LinT.K. ZhongL. SantiagoJ. Anti-inflammatory and skin barrier repair effects of topical application of some plant oils.Int. J. Mol. Sci.20171917010.3390/ijms1901007029280987
     [Google Scholar]
  94. Mauvais-JarvisP. CharransolG. Bobas-MassonF. Simultaneous determination of urinary androstanediol and testosterone as an evaluation of human androgenicity.J. Clin. Endocrinol. Metab.197336345245910.1210/jcem‑36‑3‑4524265436
     [Google Scholar]
  95. BondP. SmitD.L. de RondeW. Anabolic–androgenic steroids: How do they work and what are the risks?Front. Endocrinol. (Lausanne)202213105947310.3389/fendo.2022.105947336644692
     [Google Scholar]
  96. BishtA HemrajaniC RathoreC DhimanT RoltaR UpadhyayN Hydrogel composite containing azelaic acid and tea tree essential oil as a therapeutic strategy for Propionibacterium and testosterone-induced acne.Drug Deliv Transl Res.202212102501251710.1007/s13346‑021‑01092‑4
     [Google Scholar]
  97. SharmaG. YachhaY. ThakurK. MahajanA. KaurG. SinghB. RazaK. KatareO.P. Co-delivery of isotretinoin and clindamycin by phospholipid-based mixed micellar system confers synergistic effect for treatment of Acne vulgaris.Expert Opin. Drug Deliv.20211891291130810.1080/17425247.2021.191961833870824
     [Google Scholar]
  98. LuL. LaiH. PanZ. HuT. HouX. CaoK. JuQ. Clinical and histopathological characteristics in patients with scarring folliculitis type of acne inversa.Dermatoendocrinol201791e136157510.1080/19381980.2017.136157529484097
     [Google Scholar]
  99. GuY BianQ ZhouY HuangQ GaoJ Hair follicle-targeting drug delivery strategies for the management of hair follicle-associated disorders.Asian J. Pharm. Sci.202217333335210.1016/j.ajps.2022.04.00335782323
     [Google Scholar]
  100. WangY. HataT.R. TongY.L. KaoM.S. ZouboulisC.C. GalloR.L. HuangC.M. The anti-inflammatory activities of Propionibacterium acnes CAMP factor-targeted acne vaccines.J. Invest. Dermatol.2018138112355236410.1016/j.jid.2018.05.03229964032
     [Google Scholar]
  101. AgamiaN. El-NagdyS. El-ArinyA. A split face comparative study using a novel triple combination therapy for the treatment of persistent post acne erythema.Dermatol. Ther.2022354e1532710.1111/dth.1532735060229
     [Google Scholar]
  102. SalmanianM ShirbeigiL Hashem-DabaghianF MansouriP AzizkhaniM AlaviS The effects of myrtle (Myrtus communis) and clindamycin topical solution in the treatment of mild to moderate Acne vulgaris: A comparative split-face study.J. Pharmacopuncture202023422022910.3831/KPI.2020.23.4.22033408898
     [Google Scholar]
/content/journals/cdt/10.2174/0113894501335548250123072644
Loading
Assessing Anti-Acne Potentials Via In vitro, Ex vivo, and In vivo Models: A Comprehensive Approach
Curr Drug Targets 26, 435 (2025); https://doi.org/10.2174/0113894501335548250123072644
/content/journals/cdt/10.2174/0113894501335548250123072644
/content/journals/cdt/10.2174/0113894501335548250123072644
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Acne grading system; acne vulgaris; animal models; cell line studies; Propionibacterium acne, epilepsy

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test